Psychedelic News

Get a Roundup of Psychedelic News Stories in Your Inbox.

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Dr. Matthew Johnson: Psychedelics, Consciousness, DMT Experiences & The CIA

In this much anticipated Psychedelic Spotlight podcast, we get to see James from The Psychedelic Investor and Dr. Matthew Johnson of Johns Hopkins University discuss a broad range of topics surrounding psychedelics and their effectiveness…

Field Trip Health Treating Depression With Ketamine-Assisted Therapy All Across North America (FTRP)

Ronan Levy, founder of Field Trip Health (NASDAQ: FTRP, TSX: FTRP), joins Psychedelic Spotlight's Swati Sharma to discuss the widening research into psychedelic medicines and how they can be used to help patients in therapy. Field Trip Health…

Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain Injury & Addiction (WESA)

Wesana Health's Dr. ABID NAZEER - The Parallels Between Brain Injury & Addiction (WESA) Dr. Nazeer is the Founder and President of APS Ketamine/Advanced Psychiatric Solutions, which was recently acquired by Wesana Health (OTC: WSNAF, CSE:…

Why It’s Smart to Put Down Your Phone and Start Journaling Instead

Journaling is a key practice for integrating psychedelic experiences into our everyday lives, but it’s also an effective analog tool that can help reclaim our lives from the strong pull of the digital world.
Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy TrialShutterstock.com

Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy Trial

Chief Medical Officer Dr. Guy Goodwin clarifies "COMP360 psilocybin therapy was generally well-tolerated" by patients with treatment-resistant depression, despite some adverse reactions from subjects in the study.

Dr. Matthew Johnson: Psychedelics, Consciousness, DMT Experiences & The CIA

In this much anticipated Psychedelic Spotlight podcast, we get to see James from The Psychedelic Investor and Dr. Matthew Johnson of Johns Hopkins University discuss a broad range of topics surrounding psychedelics and their effectiveness…

Can Psychedelics Cure Chronic Pain? This Promising Study Lays Groundwork for Future Clinical Trials

Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating with psychedelics.
New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat DepressionShutterstock.com

New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression

“If the results are confirmed in subsequent studies ... antidepressants may no longer need to be stopped for psilocybin treatment,” says MindMed Executive President Dr. Miri Halperin Wernli.

Field Trip Health Treating Depression With Ketamine-Assisted Therapy All Across North America (FTRP)

Ronan Levy, founder of Field Trip Health (NASDAQ: FTRP, TSX: FTRP), joins Psychedelic Spotlight's Swati Sharma to discuss the widening research into psychedelic medicines and how they can be used to help patients in therapy. Field Trip Health…
New Florida Bill Proposes Decriminalization of Psychedelics (and Every Other Illegal Drug)

New Florida Bill Proposes Decriminalization of Psychedelics (and Every Other Illegal Drug)

A new bill filed in Florida has proposed the decriminalization of psychedelics, along with the rest of currently illegal drugs, and the promotion of rehabilitation instead of criminalization for drug-related offenses. Democratic Representative…
Combining Psychedelics: Is It Safe?

Combining Psychedelics: Is It Safe?

Mixing psychedelics goes by many names in pop culture: hippie flipping (MDMA and mushrooms) and candy flipping (MDMA and LSD), to name two. Depending on how you go about it, the experience can be life-affirmingly euphoric or severely overwhelming. But is it ever worth the risk?

Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain Injury & Addiction (WESA)

Wesana Health's Dr. ABID NAZEER - The Parallels Between Brain Injury & Addiction (WESA) Dr. Nazeer is the Founder and President of APS Ketamine/Advanced Psychiatric Solutions, which was recently acquired by Wesana Health (OTC: WSNAF, CSE:…
Psychedelic Business Spotlight: November 26

Psychedelic Business Spotlight: November 26

This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy more accessible in NYC.

Numinus Wellness CEO Discusses MAPS Partnership & How Psychedelics Will Change Society

In this episode James, from The Psychedelic Investor, sits down with Numinus Wellness’ (OTC: NUMIF, TSX.V: NUMI) CEO Payton Nyquvest for the Psychedelic Spotlight Podcast. Numinus is a Psychedelic Medicines company focused on scaling up…

MindCure CEO Kelsey Ramsden – The Psychedelic Space Is Unlike Any Other Drug Development Sector

In this interview with Kelsey Ramsden, CEO on MindCure Health (CSE:MCUR) (OTC: MCURF), David Flores, CEO of Global Trac Solutions and Swati Sharma, Media Director of Psychedelic Spotlight, discuss a few interesting topics that surround the…
PharmaTher Believes Ketamine Could Treat This Rare Neurological ConditionShutterstock.com

PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition

,
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.
Sena Maria On The Benefits of Microdosing

Sena Maria On The Benefits of Microdosing

In this episode, Sena Maria gives us an overview of her Microdosing Activation program and explains some of the benefits of microdosing.
Doug Drysdale Cybin

Doug Drysdale On How CYB-003 Is Better Than Psilocybin

In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to treat depression and other mental health issues.
How the COVID Pandemic Inspired Wakeful Travel's Psychedelic Integration Journals

How the COVID Pandemic Inspired Wakeful Travel’s Psychedelic Integration Journals

A travel journal company pivots from external trips to those unfolding in the mind, and the psychedelic community is embracing the one-of-a-kind integration workbook with open arms.
Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized CoShutterstock.com

Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities

“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” says Cybin Chief Clinical Officer Dr. Alex Belser.
Jon Stewart Wants to Try Microdosing Psychedelics, TooShutterstock.com

Jon Stewart ‘Would Love’ to Try Microdosing Psychedelics

The comedian publicly expresses interest in the mental health treatment trend the same day as Paul Stamets' massive microdosing study results were published.
New Evidence Microdosing Psychedelics Reduces Anxiety and DepressionShutterstock.com

New Evidence Microdosing Psychedelics Reduces Anxiety and Depression

This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.
Ayahuasca Helped Will Smith 'Surrender' and More Psychedelic Revelations From Actor's Memoir 'Will'Shutterstock.com

Ayahuasca Helped Will Smith ‘Surrender’ and More Psychedelic Revelations From Actor’s Memoir ‘Will’

“If I’m this beautiful, I don’t need #1 movies to feel good about myself,” Will Smith writes in memoir detailing his first ayahuasca ceremony.

CYBIN CEO Doug Drysdale On How CYB-003 Is Better Than Psilocybin | Next Gen Psychedelics

In this episode of the Spotlight On, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to…
How Dr. Monnica Williams Launched the First-Ever Psychedelics Master’s Program: 'Nobody Took Me Seriously'

How Dr. Monnica Williams Created Canada’s First Psychedelic Master’s Degree Program: ‘Nobody Took Me Seriously’

After two long years of preparing documents and presenting to various committees, the program is in its final stages, and the University of Ottawa will soon begin accepting applications for the fall semester.
Psychedelic Business Spotlight: November 19

Psychedelic Business Spotlight: November 19

This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.
Microdosing Psilocybin for Beginners in 5 Easy StepsShutterstock.com

Microdosing Psilocybin for Beginners in 5 Easy Steps

Journal. Measure. Schedule. Listen. Flourish. This increasingly popular practice only pays off with careful intention and execution.
Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on 'Red Table Talk'Facebook Watch / Shutterstock.com

Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on ‘Red Table Talk’

“We know nothing scientific about psychedelics and people of color and how appropriate our treatments are for people in those communities," says psychedelic researcher Dr. Monnica Wiliams.

Daniel Carcillo On Psychedelics For TBI, Wesana Partnering With MAPS & Mike Tyson Collaboration

During our time at Wonderland Miami, $PSYC CEO, David Flores, had the pleasure of sitting down with Wesana Health CEO, Daniel Carcillo, to talk about the significance of the conference and what it means to the arrival of the psychedelics industry.…
Shutterstock.com

American Overdose Deaths Reach Record High During COVID Pandemic—And New Study Shows Psychedelics Can Help

“After adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,” researchers say.

Interview with Sa’ad Shah, Managing Partner at Noetic Fund

In our conversation, Sa’ad gives us an overview of how his interest in philosophy led to his involvement with plant medicine, how the psychedelic industry is currently misunderstood and under appreciated, Noetic's portfolio selection process, and more!
Australian Doctor Sues State Over Patient Access to MDMAShutterstock.com

Australian Doctor Sues State Over Patient Access to MDMA

“People will continue to kill themselves, and my patient will continue to suffer in silence until the Victorian Government allows me to access a new treatment which may finally bring peace to a troubled mind,” says Dr. Eli Kotler.
How does Time of Day Influence LSD Microdosing? New Study Hopes to Find Out

How does Time of Day Influence LSD Microdosing? New MindMed Study Hopes to Find Out

"Our goal is to provide insight on key parameters that may impact and explain the mechanisms behind low-dose treatments," says MindMed Executive President Dr. Miri Halperin Wernli.
DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production QuotasShutterstock.com

DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production Quotas

Drug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide public interest in hallucinogenic controlled substances research.”

Animals That Eat Psychedelics and Enjoy the Trip

Is drug use a natural instinct? From mandrils ingesting ibogaine to deer munching on red and white-spotted mushrooms like antlered Super Mario characters, humans aren’t the only mammals that seek out and consume psychoactive substances.

Psychedelic Business Spotlight: November 12

This week in psychedelic business news: two of the biggest players in the industry unveil big data; Numinus Wellness helps MAPS expand MDMA study; and Ketamine One announces IPO intention.
Shutterstock.com

Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy Session

And the results, according to the participants, were nothing short of "profound."
Jada Pinkett Smith Reveals Psilocybin Helped Her Overcome ‘Crippling Depression' in 'Red Table Talk' About PsychedelicsFacebook / Shutterstock.com

Jada Pinkett Smith Reveals Psilocybin Helped Her Overcome ‘Crippling Depression’ in ‘Red Table Talk’ About Psychedelics

Will Smith's wife, and her son, Jaden, lead a "Red Table Talk" about psychedelics with author Michael Pollan and other guests.
MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into CanadaShutterstock.com

MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into Canada

Rick Doblin's organization partners with Numinus Wellness to manage the Canadian sites where therapists will be administering the psychedelic therapy.
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly ReduceShutterstock.com

Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce

,
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways' novel drug formulation COMP360.
Forgotten Psychedelics: What Is 2C-B?

Forgotten Psychedelics: What Is 2C-B?

4-Bromo-2,5-dimethoxyphenethylamine (also known as Nexus, Erox, or 2C-B) was synthesized by a famous American pharmacologist and psychonaut, Alexander Shulgin, in 1974. 
Stunning MDMA-Assisted Therapy Results for PTSD Wows NBC 'Today' Show AnchorsNBC/Today Show

Veteran Who Cured PTSD with MDMA-Assisted Therapy Wows NBC ‘Today’ Show Anchors

"This treatment is the reason that my son has a father instead of a folded flag," a once-suicidal Iraq War veteran tells Savannah Guthrie.
Cybin’s Novel Analog Shows Multiple Advantages Over Oral Psilocybin

Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the ‘Superior Molecule’

Pre-clinical studies demonstrated multiple advantages, including less patient variability, faster onset of action, shorter duration of effect, and improved brain penetration.
Psychedelic Business Spotlight: November 5

Psychedelic Business Spotlight: November 5

This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Why We're Excited About Compass Pathways New Clinical Trial Treating PTSD With PsilocybinShutterstock.com

Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin

,
Compass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial, using psilocybin (the active ingredient in magic mushrooms) to treat PTSD, and there are multiple reasons to be excited about it. The Phase-2…
Shutterstock.com

FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics

This trial, using Filament Health's botanical drug candidates, is the first to assess the direct administration of psilocin.
Psychedelic Mom and Therapist Explains How Giving Birth Was Like a ‘Wild Acid Trip’E_serebryakova / Shutterstock.com

Psychedelic Mom and Therapist Explains How Giving Birth Was Like a ‘Wild Acid Trip’

Kate Kincaid, who specializes in psychedelic integration and ketamine-assisted therapy, appears on the premiere of our new series "Spotlight in Focus" to share parallels between labor and tripping on psychedelics.
Detroit Voters Decriminalize Plant Psychedelics

Detroit Voters Decriminalize Plant Psychedelics

As the decriminalization movement sweeps through Michigan, Detroit becomes the largest city in the state to decriminalize entheogenic plants.

Interview with Awais Spall, Functional Diagnostic Nutrition Practitioner at Integrative Oasis

In this conversation, we discuss some critical points such as how he managed to heal himself through the use of Ayurveda and functional medicine which led him down the path to working with these interesting modalities, how ancestral healing has the ability to significantly influence an individual's wellbeing overall, how his practice uses entheogens to cure physical ailments such as Traumatic Brain Injury, and more!
TRIPP Wants You to 'Be Here Now,' With or Without Ram DassLove Serve Remember Foundation / TRIPP

TRIPP Wants You to ‘Be Here Now,’ With or Without Ram Dass

Psychedelic Spotlight trips with Ram Dass at the 50th anniversary celebration of the spiritual teacher's iconic book.
Lil Nas X Says Psychedelics Helped Him 'Open Up' to Write Debut Album ‘Montero’Shutterstock.com

Lil Nas X Says Psychedelics Helped Him ‘Open Up’ to Write Debut Album ‘Montero’

Pop star says in new interview that tripping on psilocybin enabled him, for the first time, to "write actual stories about my life and put it into my music."
Could the Psychedelics Boom Go Bust? A Conversation with Cybin Chief Clinical Officer Dr. Alex Belser

Can the Psychedelics Boom Go Bust? A Conversation with Cybin Chief Clinical Officer Dr. Alex Belser

"Something that people used to speak about only in whispers is now standard policy," says the psychedelics researcher, with 20 years of experience, in a wide-ranging Q&A.
Parents Are Open to Ketamine Therapy for Kids, Study FindsShutterstock.com

Parents Are Very Open to Ketamine Therapy for Kids, Study Finds

“As parents maintain decision-making capacity of their child’s medical care, parental consent is a key factor in the adoption of new treatments for adolescents," study authors explain.
Are We Being Exposed to Psychedelics More Than Ever Before? Survey Says...It's ComplicatedShutterstock.com

Are We Being Exposed to Psychedelics More Than Ever Before? Survey Says…It’s Complicated

A study of American newspaper mentions of psychedelics doesn't stack up to what leaders in the industry are observing in the media landscape at large.
Forgotten Psychedelics: LSA — Also Known as OloliuquiCarolina Jaramillo / Shutterstock.com

Forgotten Psychedelics: LSA — Also Known as Ololiuqui

Meet LSA: LSD’s less intense but introspective cousin found in the seeds of morning glories and other plants. Here’s everything you need to know about the origins, effects, and uses of LSA.

Psychedelic Business Spotlight: October 29

This week in psychedelic business news: MindMed's MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure partner to heal alcoholism.
Psychedelic Users Experienced Less Psychological Stress During COVID-19, Study FindsModvector / Shutterstock.com

Psychedelic Users Experienced Less Psychological Stress During COVID-19 Lockdowns, Study Finds

Researchers found stress further reduced for the participants that use psychedelic drugs at least once every six months.
Driver's Licenses to Trip on Psychedelics by 2035? Rick Doblin Maps Out the Future of 'Spiritualized Humanity'MAPS / Shutterstock.com

Driver’s Licenses to Trip on Psychedelics by 2035? Rick Doblin Maps Out the Future of ‘Spiritualized Humanity’

The MAPS founder, who will speak at psychedelic conference Wonderland Miami next month, predicts clinics that administer the medicines will become licensing bodies for personal use.
‘Dune’ Is a Psychedelic Sci-Fi Hit: 5 Ways Mushroom Magic Inspired Frank Herbert’s Masterpiece

‘Dune’ Is a Psychedelic Sci-Fi Hit: 5 Ways Mushroom Magic Inspired Frank Herbert’s Masterpiece

From mind-expanding spice to honoring sacred medicine, Denis Villeneuve’s trippy new movie celebrates psychedelics throughout.
FDA Authorizes Device to Quantify Psychedelics’ Effects on the BrainShutterstock.com

FDA Authorizes Cybin Device to Quantify Psychedelics’ Effects on the Brain

"This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding," says Cybin's chief clinical officer.
Psychedelic Patents Should Be Limited, Harvard Law Experts SayArtur Szczybylo / Shutterstock.com

Psychedelic Patents Should Be Limited, Harvard Law Experts Say

"If a small number of companies secure wide swaths of intellectual property early on, then the beneficial impact of that shift may be blunted," warn researchers.
Psychedelics Help Heal Childhood Trauma, Study FindsFGC / Shutterstock.com

Psychedelics Help Heal Childhood Trauma, Study Finds

Researchers find that there were significantly lower levels of complex trauma symptoms and feelings of internalized shame in study participants that had used psychedelics therapeutically.

Interview with Zoe Helene, Founder of Cosmic Sister

In our conversation, we discuss some of Zoe’s formative experiences in the creative arts which led her down the path of plant medicine advocacy, core feminist issues and how psychedelics play a role in furthering women’s movements, why an emphasis on equity and representation within the budding psychedelic industry is crucial and still has a long way to go, and so much more.
Psychedelic Business Spotlight: October 22

Psychedelic Business Spotlight: October 22

This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company prepares for the Nasdaq.
How Nutrition Can Improve the Psychedelic ExperienceProstock-studio / Shutterstock.com

How Nutrition Can Improve the Psychedelic Experience

Focus on these five key nutrients to better support your body and increase the likelihood of enjoying your psychedelic experience.
Fourth Massachusetts City Decriminalizes Psychedelic PlantsShutterstock.com

Fourth Massachusetts City Decriminalizes Psychedelic Plants

The resolution, however, does not authorize the commercial sale of entheogenic plants and fungi, nor cultivation for large-scale distribution.

WONDERLAND MIAMI: The Largest Psychedelic Business Event EVER | Ft. Mike Tyson, Lamar Odom & More

Patrick Moher, CEO of Microdose and the Microdose.buzz team are hosting the largest psychedelic business event ever on Nov 8-9, 2021! Wonderland Miami will be hosted at the Adrienne Arsht Center for the Performing Arts, one of the largest…
Psychedelics and Sports: Can They Propel Athletes to Unprecedented Pinnacles of Ability?filip robert / agsandrew / Shutterstock.com

Psychedelics and Sports: Can They Propel Athletes to Unprecedented Pinnacles of Ability?

While scientific literature on athleticism and psychedelics is still in its embryonic stages, there’s a deep well of anecdotal evidence suggesting that psychedelics could bring athletes to new peaks of performance.
UK Prime Minister Boris Johnson to Consider Legalizing PsilocybinFrederic Legrand - COMEO / HaHanna/ Shutterstock.com

UK Prime Minister Boris Johnson to Consider Legalizing Psilocybin

The leader of the Conservative Party in the United Kingdom tells a Member of Parliament "we will consider the Advisory Council on the Misuse of Drugs' recent advice on reducing barriers to research with controlled drugs."

Interview with Patrick Moher, CEO of Microdose

In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a pandemic), who and what to expect at the event, and why Wonderland Miami is not just any other conference, but a one-of-a-kind experience. 

Psilocybin Study for Tobacco Addiction Receives First Federal Psychedelics Research Grant in 50 Years

A Johns Hopkins Medicine professor says "it was only a matter of time," while lead researcher calls the historic grant "monumental" for the psychedelics movement.
Melissa Etheridge Comes Out for Psychedelics: 'Psilocybin Is a Real Key'

Melissa Etheridge Comes Out for Psychedelics: ‘Psilocybin Is a Real Key’

"Let's spend the time researching, looking into how these plant medicines were made to help us," the two-time Grammy winner says during end-of-life psychedelic conference.
Comedy Superstar Russell Peters Invites the World to Watch His First Psychedelic TripJoe Seer / Shutterstock.com

Comedy Superstar Russell Peters Invites the World to Watch His First Psychedelic Trip

The comedian and Netflix star will ingest psilocybin truffles from Red Light Holland, a company for which he serves as chief creative officer.
Return Health Believes Psychedelics Can Treat Dementia

This New Company Believes Psychedelics Can Treat Dementia

There is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer "unprecedented" potential.
Preventing Sexual Abuse in Psychedelic Therapy

Preventing Sexual Abuse in Psychedelic Therapy

Recent study interviews 23 underground psychedelic therapy practitioners about the biggest ethical issues and boundary challenges they face while sharing such an intimate space with clients.

Psychedelic Business Spotlight: October 15

This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs ketamine.
Indigenous People and Psychedelics Can Teach Us 'One of the Most Important Lessons' Society Has Forgotten

Indigenous People and Psychedelics Can Teach Us ‘One of the Most Important Lessons’ Society Has Forgotten

Ethnobotanist Joseph Mays discusses "the key to all life," and Indigenous reciprocity on the latest Psychedelic Spotlight Podcast episode.
Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Researchers say there are several ways classic psychedelics could, directly and indirectly, lead to improved cardiometabolic health.
Why Psychedelic Stocks Have Crashed in the Last 3 Months

Why Psychedelic Stocks Have Crashed in the Last 3 Months

Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.
FDA Backs Ketamine for Rare Pain Disorder with No Current Medical Treatment

FDA Backs Ketamine to Treat This Rare and Debilitating Pain Syndrome

Food and Drug Administration grants psychedelic biotechnology company PharmaTher orphan drug designation for ketamine to treat complex regional pain syndrome.

Interview with Joseph Mays, IRI Program Director at Chacruna

In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us to understand the Indigenous philosophy of interrelatedness between one another and our ecosystems, the importance of considering sacred reciprocity to Indigenous peoples and their land, and how Chacruna's Indigenous Reciprocity Initiative is making it simple for companies to give back to the societies who have cultivated psychedelic medicine.
You Can Now Buy Marley One Functional Mushrooms on Amazon

You Can Now Buy Marley One Functional Mushrooms on Amazon

Silo Wellness CEO Douglas K. Gordon tells Psychedelic Spotlight that this is a "crucial" step toward "the mainstream acceptance of psychedelics and overall de-stigmatization of mushrooms, by way of the functional category."
Pennsylvania Lawmakers File Psilocybin Research Bill for Veterans and First Responders

Pennsylvania Lawmakers File Psilocybin Research Bill for Veterans and First Responders

“As traditional treatment has proven inadequate at both the individual and public health level, the Commonwealth has a responsibility to research alternative options," the bill's sponsors write in a memo.
On Sacred Reciprocity: Giving Back to our Indigenous Predecessors in the Psychedelic Movement

On Sacred Reciprocity: Giving Back to our Indigenous Predecessors in the Psychedelic Movement

We owe so much of our understanding of these compounds to Indigenous peoples, and the widespread bioprospecting projects taking place today would not be prevalent without the inherent harm placed on local groups historically.
How Mindset Pharma Is Making and Defining 'Next-Generation Psychedelic Drugs'

How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.
Arcata Becomes Third California City to Decriminalize Psychedelics

Arcata Becomes Third California City to Decriminalize Psychedelics

Planting, cultivating, purchasing, transporting, distributing, possessing these plants and fungi will be the lowest law enforcement priority for the city.
Psychedelic Business Spotlight: October 8, 2021

Psychedelic Business Spotlight: October 8, 2021

This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson's Disease.
Best Areas to Forage for Psychedelic Mushrooms in the United States

These Are the Best Areas to Forage for Psychedelic Mushrooms in the United States

A new study describes the Pacific Northwest as “by far the best place in America to go looking for psychedelic mushrooms."

Interview with Bright Minds Biosciences’ CEO Ian McDonald

In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading…
Why This California City Recriminalized Peyote

Why This California City Recriminalized Peyote

The sacred entheogen was also excluded from Seattle's resolution to decriminalize natural psychedelics.

Interview with James Lanthier, CEO of Mindset Pharma

In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take the drug to clinical trials, and why next generation drugs are an important commercial opportunity for anyone looking to invest in the psychedelic sector.

Interview with Ian McDonald, CEO & Director of Bright Minds Biosciences

In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss most of Bright Minds’ major projects, including using new psychedelic medicines to treat chronic pain. This is exciting, since it could not only help people with chronic pain issues such as fibromyalgia, but it could also put a dent in the opioid use crisis by preventing people from being prescribed opioids by their doctors to treat pain. 
Seattle Decriminalizes Natural Psychedelics

Seattle Decriminalizes Natural Psychedelics

Seattle City Council unanimously approves a resolution declaring entheogen-related activities should be among lowest law enforcement priorities.
Will Smith's Son, Jaden, Is Also Into Psychedelics

Will Smith’s Son, Jaden, Is Also Into Psychedelics

But the 23-year-old actor and musician doesn't specify which psychedelics he uses to explore "mystical states of consciousness."
World Boxing Association Partners with Psychedelics Company to Improve Brain Injury Treatment for Athletes

World Boxing Association Partners with Psychedelics Company for TBI and PTSD Research

"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family," says WBA president Gilberto Jesús Mendoza.

Will Smith Comes Out of the Psychedelic Closet

And it sounds like we'll hear more about his psychedelic experiences on ayahuasca in his upcoming memoir, simply titled "Will."
Psychedelic Business Spotlight: October 1, 2021

Psychedelic Business Spotlight: October 1, 2021

This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes a leap in treating PTSD; Delix raises big bucks; and BetterLife Pharma patents solution for cluster headaches.
86% of Oregon Adults Considering Psilocybin Are Interested in Microdosing

Vast Majority of Oregon Adults Interested in Psilocybin Want to Try Microdosing

On the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was.
World's Richest Person Elon Musk: 'People Should Be Open to Psychedelics'

World’s Richest Person Elon Musk: ‘People Should Be Open to Psychedelics’

The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted at using DMT.
Why NeonMind Is Betting on Psilocybin to Curb the Global Obesity Epidemic

Why NeonMind Is Betting on Psilocybin to Curb the Global Obesity Epidemic

The psychedelic bioscience company's top advisor tells Psychedelic Spotlight that psilocybin "affects at least the 5h2C receptor, which is dedicated towards appetite and appetite suppression."
Psychedelic Industry Conference Wonderland Miami Unites Leaders and Celebrity Advocates

Wonderland Miami Brings Together Psychedelic Industry Leaders and Celebrity Advocates

Organizers of the largest psychedelic business event ever promise it's not just a conference, but an experience.
Mind Cure Health Targeting Hypoactive Sexual Desire Disorder with MDMA

Mind Cure Health Targeting Hypoactive Sexual Desire Disorder with MDMA

“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has real promise," says CEO Kelsey Ramsden

Interview with Trevor Millar, Advisor, NeonMind Biosciences

In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused on developing to help tackle obesity. Obesity is one of the more prevalent health conditions today affecting millions of individuals worldwide. The World Health Organization has claimed that obesity has reached epidemic proportions globally with at least 2.8 million people dying each year as a result of being overweight or obese. 
How Cybin Is 'Revolutionizing' Mental Healthcare with Novel Psychedelic Compounds

How Cybin Is ‘Revolutionizing’ Mental Healthcare with Novel Psychedelic Compounds

CEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions of people suffering around the globe.
Survey Shows American Psychologists Still Don't Really Understand Psychedelics

Survey Shows American Psychologists Still Don’t Really Understand Psychedelics

Less than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.
Psychedelic Business Spotlight: September 24, 2021

Psychedelic Business Spotlight: September 24, 2021

This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic compounds; DMT and ibogaine clinical trials show promise; and stock news for psychedelic investors.

‘Nine Perfect Strangers’ Director Calls Psychedelics a ‘Salvation of Humanity’

But the psychedelic community is concerned the Hulu series is full of "misinformation" about psychedelic-assisted therapy, and think the show may be harmful to the progressive movement.
Psychedelics Helped Me Heal From Sexual Trauma and Research Shows I'm Not Alone

Psychedelics Helped Me Heal From Sexual Trauma and Research Shows I’m Not Alone

Reprocessing sexual trauma is a difficult task, but psychedelics are presenting themselves as a powerful tool to help survivors.

Interview with Matt Zemon, Co-Founder, Psychable

In our conversation with Matt, we tackle a variety of extremely important and highly-relevant subject matters such as how technology can be utilized to enhance the community of psychedelic healing, conscious capitalism, corporate responsibility, and how companies like Psychable are willing to go out of their way to connect with investors who are motivated not only by profit, but a company’s ability to contribute to the greater good of humanity.
How Psychedelics Can End the Suicide Epidemic

How Psychedelics Can Help End the Suicide Epidemic

There is increasing scientific evidence that a variety of psychedelics can be used to treat a number of the risk factors linked to suicide, in addition to reducing suicidality.

Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders

Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.
Here's How Many Billions of Dollars the Global Psychedelic Market May Be Worth by 2026

Here’s How Many Billions of Dollars the Global Psychedelic Market May Be Worth by 2026

Recent analysis cites positive results of clinical psychedelic trials, coupled with a large amount of capital investment into biotech companies.
Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

Why Psychedelic Spotlight Is Taking the North Star Ethics Pledge

"We are committed to leveraging this pledge as a powerful guide and resource to help us earn trust and to never lose sight of our ability to help contribute to the greater good of humanity," says our CEO David Flores.
Psychedelic Business Spotlight: September 17, 2021

Psychedelic Business Spotlight: September 17, 2021

This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across the Nordics.
United States' First Actively Managed Psychedelics ETF Launches on NYSE Arca

United States’ First Actively Managed Psychedelics ETF Launches on NYSE Arca

PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier this year.
How 4 Indigenous Cultures Currently Use Psychedelics

How 4 Indigenous Cultures Currently Use Psychedelics

Explore how the Mazatecs, the Shipibo People, Yanomami People, and Africans practicing the Bwiti religion continue to use various entheogens to this day.
How Mind Medicine Australia is Tackling Australia’s Mental Health Crisis with Psychedelics

How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics

Charity co-founder Tania de Jong says Covid-19 pandemic has led to "a huge spike in mental health issues including, very sadly, suicides," and she believes psychedelics are a solution.

Why the Psychedelic Drug Market is Experiencing Major Growth

David Flores, CEO of Global Trac Solutions (PSYC), joins Cheddar to discuss the company's digital media platform 'Psychedelic Spotlight', factors contributing to a more open-minded approach to psychedelics among the scientific and medical…

HAVN Life Sciences Update

HAVN Life Sciences Inc. CEO, Tim Moore, updates the recent launch of its new line of natural health products and more. *To learn more about the company featured in this video and the work they’re doing, visit their website: https://havnlife.com…

Senator Scott Wiener Discusses Senate Bill 519

In this Psychedelic Spotlight exclusive, we speak with California Senator, Scott Wiener (D-San Francisco), to discuss Senate Bill 519 (SB-519) which aims to decriminalize the possession and sharing of certain psychedelics within the state…

Psychedelic Spotlight Interview with Anthony Tennyson

In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction. In our conversation…

Psychedelic Spotlight Interview with Daniel Carcillo

In this episode of the Psychedelic Spotlight podcast, we catch up with Daniel Carcillo, Founder, and CEO of Wesana Health, to talk about the company's recent listing on the #CSE, their plans to uplist to the NASDAQ, and their recently formed…

Psychedelic Spotlight Interview with James Hallifax

In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor, an emerging media company covering the medicinal psychedelics space and partner of Psychedelic Spotlight. In our conversation…
Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Podcaster and author of "The 4-Hour Work Week" will gift the university's Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.

Interview with Doug Drysdale, CEO, Cybin Inc

Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.

Psychedelic Drug Use Among College Students Increased During Covid-19 Pandemic

Annual survey finds college students drank less during the pandemic, in favor of smoking more marijuana and experimenting with hallucinogens.
Detroit Voters Can Decriminalize Psychedelic Plants This November

Detroit Voters Can Decriminalize Psychedelic Plants This November

The proposal asks voters if the city should "decriminalize to the fullest extent permitted under Michigan law the personal possession and therapeutic use of entheogenic plants by adults."
Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve

Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve

"HPPD is a discomfort. Some people have it for 10, 15, 20 years and they regret the day they did the drug that caused it," says the CEO of Ehave.
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

"Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
The Legal Status of Psychedelics Around the World

The Legal Status of Psychedelics Around the World

In Brazil, there have been no instances of an individual being punished for the consumption, cultivation, or possession of magic mushrooms.
Psychedelic Business Spotlight: Big Week for Research and Clinical Trials

Psychedelic Business Spotlight: September 10, 2021

This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.
Moms on Mushrooms: Inside the Psychedelic Parenting Trend

Moms on Mushrooms: Inside the Psychedelic Parenting Trend

They’re not quite hippies, and they’re not quite 20-year-olds on the search for existential assurance. Nope. They’re moms, and they’re coming out of the psychedelic closet to share how microdosing has helped them become better parents.

Walled Garden: Fighting for Inclusivity and Accessibility in the Psychedelic Renaissance

As the new industry blooms, researchers and other professionals are fighting to break down barriers to participation, information, and psychedelics themselves.
University of Ottawa Offers Canada's First Psychedelic Studies Program

University of Ottawa Offers Canada’s First Psychedelic Studies Program

And since the classes are online, students can live anywhere in the world while taking Psychedelic and Spiritual Studies courses at the university.
Michigan Senators Propose Bill Legalizing Plant-Based Psychedelics

Michigan Senators Propose Bill Legalizing Plant-Based Psychedelics

"Decriminalization of entheogenic substances makes sense," says Senator Jeff Irwin. "Let's stop wasting time and money making more victims of the War on Drugs."

Interview With Michelle Janikian, Author, Host & Editor at Psychedelics Today

Michelle opens up about how her work as a cannabis writer led her down the path of psychedelics, her interest in safe magic mushroom use and why she was compelled to write her guidebook Your Psilocybin Mushroom Companion.
4 Ways Psychedelics Can Positively Transform Women's Mental Health

4 Ways Psychedelics Can Positively Transform Women’s Mental Health

Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.

Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%

The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
3 Reasons Why Diversity, Equity and Inclusion Matter in the Psychedelic Industry

Why Diversity, Equity and Inclusion Are Vital to the Psychedelic Industry

Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should "harness the power of diversity."
Psychedelic Business Spotlight: September 3, 2021

Psychedelic Business Spotlight: September 3, 2021

"Magic Truffle" producer and distributor Red Light Holland has had a very busy week, and Filament Health files a "milestone" patent.
Ketamine One Clinics Offer Scented Virtual Reality Psychedelic Trips

Ketamine One Partners with OVR Technology to Provide Scent-Enabled VR Psychedelic Experiences

Take a whiff of the latest development in virtual reality technology available to further immerse patients in psychedelic-assisted therapy.

DEA Proposes Huge Increase to Psilocybin and Psilocin Quotas for Research Purposes

In its proposed revised 2021 quotas, the DEA suggests 4900% increase in the allowed quantities of psilocybin for research and clinical trial purposes.
Take Tastier Trips with This Psilocybin Cookbook

The Joy of Cooking with ‘Shrooms: Making Psilocybin More Palatable

Virgina Haze, the co-author of "The Psilocybin Chef Cookbook," promises a psychedelic experience "can be delicious as well as trippy."
Psychedelic Sector Reaches International Supply Chain Milestones

Psychedelic Sector Reaches International Supply Chain Milestones

Canadian psychedelics production company Red Light Holland announces largest legal sale and import of psilocybe truffles.

Interview With Steven Huang, DEI Consultant at MAPS and Numinus

Steven's consultancy company, Millennial HR Design, focuses on the intersection of DEI and psychedelics, where he intends to be a leverage point for the psychedelics industry to better understand their impact on marginalized communities. With nearly 10 years of industry experience, Steven hopes for more diverse and equitable representation in the psychedelic space. 
How to Navigate a 'Bad Trip' on Psychedelics

How to Navigate A Challenging Psychedelic Trip

,
Psychedelic facilitator and guide Nick Levich shares his best advice for facing inevitable discomfort during these profound experiences.
Mindset Pharma's DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge

Mindset Pharma’s DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge

,
“The data suggests that we have a new drug that may be at least as effective, if not more effective, than 5-MeO-DMT and, more importantly, it looks like it is much safer," says Mindset Pharma CEO James Lanthier.
Stoned Ape Theory 101: Pseudoscience or Psychedelic Wonder?

The Stoned Ape Theory: Pseudoscience or Psychedelic Origin of Modern Man?

Did early humans accelerate evolution by tripping balls on psychedelic mushrooms? One psychonaut ethnobiologist says: absolutely.
Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia

Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia

“Australian native ‘magic mushrooms’ may have evolved different methods for psilocybin production and offer adaptations that are preferential for use in clinical treatments," explains University of Queensland mycologist Dr. Alistair McTaggart.
I Drank a 'Mushroom Latte' Every Morning for Two Weeks: Here's How I Felt

I Drank a ‘Mushroom Latte’ Every Morning for Two Weeks: Here’s How I Felt

Everyday Dose is a tasty coffee replacement, which is easy to make and loaded with healthy benefits.
California Bill Decriminalizing Psychedelics Delayed Until 2022

California Bill Decriminalizing Psychedelics Delayed Until 2022

SB 519 would decriminalize the personal use of psilocybin, psilocyn, MDMA, LSD, DMT, mescaline (excluding peyote), and ibogaine, including in group counseling and community-based healing settings.
Psychedelic Business Spotlight: August 27, 2021

Psychedelic Business Spotlight: August 27, 2021

Delic establishes medical board to oversee psychedelic treatment protocols, cool new delivery systems investigated for psychedelics, and VR meets psychedelic therapies, finally. 
MindSet Pharma Says Its Proprietary Psilocybin Formula Is the 'Perfect Microdosing Drug'

MindSet Pharma Says Its Proprietary Psilocybin Formula Is the ‘Perfect Microdosing Drug’

"The potential market for microdosing could be absolutely enormous because it is easier, more convenient, and more familiar," says Mindset Pharma CEO James Lanthier.
Kacey Musgraves Says ‘Life-Changing’ Psilocybin Trip Transformed Her Trauma Into New Album

Kacey Musgraves Says ‘Life-Changing’ Psilocybin Trip Transformed Her Trauma Into New Album

This isn't the first time the hit songwriter has turned to psychedelics for therapy, either.
MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders

MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders

MindMed is currently conducting several clinical trials using psychedelic-inspired medicines, including studying LSD experiential therapy for anxiety, LSD microdosing for adult ADHD, and 18-MC for opioid withdrawal.

Interview With Chris Kilham, Medicine Hunter Inc.

Chris works alongside companies to develop plant-based food and medicinal products, helping turn them into market successes. He has conducted medicinal plant research and sustainable botanical sourcing in over 45 countries, and has been featured on a number of platforms such as The New York Times, The Dr. Oz Show, Business Insider, CNN, VICE, and much more. 
3 Microdosing Alternatives to Relieve Stress

3 Microdosing Alternatives to Relieve Stress

Although the trend is hot, it's still largely illegal, so consider incorporating these three stress relievers into your life. They're free, effective, and legal.
University of Wisconsin-Madison Launches New Psychedelic Research Center

University of Wisconsin-Madison Launches New Psychedelic Research Center

This school offers the first accredited American degree focused on the study and therapeutic development of psychedelic compounds and related psychoactive drugs.
TRIPP Acquires PsyAssist to Empower Psychedelic Therapies with Virtual Reality

TRIPP Acquires PsyAssist to Empower Psychedelic Therapies with Virtual Reality

Clinicians are currently using TRIPP to help immerse patients into alternative realities and to support patients’ wellbeing before, during, and after ketamine-assisted therapy.
Psychedelics May Decrease Racial Trauma Symptoms Among People of Color

Psychedelics May Decrease Racial Trauma Symptoms Among People of Color

Study authors write, "Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience."

Decriminalize Nature Co-Founder Carlos Plazola Wants to Free Entheogens Everywhere

,
Since May 2019, nine cities and the state of Oregon have decriminalized psychedelics. Carlos Plazola has had his hand in nearly all of them. 
Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.

Psychedelic Business Spotlight: August 20, 2021

This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing. 

Spiritual Tourism: The Toxic Impact on Indigenous Peoples and Ethical Steps Forward as Psychedelics Boom

Jessika Lagarde, the co-founder of Women on Psychedelics, explores the negative impacts of psilocybin-fueled spiritual tourism on the Mazatec people in Mexico, and offers ideas for more ethical steps forward.
Field Trip Health Expands Access to Ketamine-Assisted Psychotherapy

Field Trip Health Expands Access to Ketamine-Assisted Psychotherapy

Although based in Canada, the company is building a clinical network of therapists trained in ketamine-assisted psychotherapy across the United States.
Does Ayahuasca Change Personality Like Other Psychedelics? Study Says No

New Study Explores If Ayahuasca Changes Personality Like Other Psychedelics

Recent ayahuasca study concludes mixed messages in attempt to determine if the ancient plant medicine has power to change personality, as psilocybin has shown.
Reishi Mushrooms to treat breast cancer

Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast Cancer

,
The company is also pursuing psilocybin as a possible treatment for rare cancers, but they see huge potential in researching the medicinal effects of the reishi mushroom.

Interview with Evan Levine, PsyBio Therapeutics

In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health issues and other disorders.
Why PsyBio Is Using Biosynthetic Psilocybin, Not Magic Mushrooms, to Build Better Therapeutics

Why PsyBio Is Using Biosynthetic Psilocybin, Not Mushrooms, to Build Better Therapeutics

"A mushroom is not a pharmaceutical product," CEO Evan Levine stresses, and explains why his company's method of biologically engineering psilocybin is "cheaper, faster, greener."
Canada Green Lights Country’s Third Clinical Psilocybin Study

Canada Green Lights Country’s Third Clinical Psilocybin Study

The trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses of psilocybin hold the potential to treat psychiatric disorders, including anxiety and depression.
'Have a Good Trip' Director Donick Cary Prepares Sequel 'The Adventures Continue'

‘Have A Good Trip’ Director Donick Cary Prepares a Second Dose: ‘The Adventures Continue’

The filmmaker behind the Netflix hit tells us a sequel or a series is on the way, as well as which celebrities may share more psychedelic adventures.
Beckley Psytech Raises $80 Million to Fund Psychedelic Research Pipeline

Beckley Psytech Raises $80 Million to Fund Psychedelic Research Pipeline

,
The company will use proceeds of the fundraising round to complete its ongoing Phase 1B trial on low-dose psilocybin in patients suffering from a rare headache condition with no approved medications to treat it.
First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

Researchers hope to establish whether the effects of microdosing are as profound as people say they are, since previous studies could not rule out placebo effect.

Interview With Henri Sant-Cassia

In today’s episode of the Psychedelic Spotlight podcast, we spotlight Henri Sant-Cassia, Co-Founding Partner of The Conscious Fund, a leading investment fund in the medicinal psychedelics industry, focused on early stage ventures and psychedelic medicine that are helping to deliver better outcomes for mental health, addiction and pain.